Acellular blood vessels combined human hair follicle mesenchymal stem cells for engineering of functional arterial grafts

Annals of Biomedical Engineering

Volumn 42, Issue 10, 2014, Pages 2177-2189

  Gao, Yunhe ^a   Liu, Feilin ^a   Zhang, Lihong ^a   Su, Xuejin ^a   Liu, Jin Yu ^a   Li, Yulin ^a  

^a Jilin University   (China)

Author keywords

Acellular blood vessel scaffolds; Arterial grafts; Hair follicle; Material; Mesenchymal stem cells

Indexed keywords

BIOMECHANICS; BLOOD; CELL CULTURE; CELL ENGINEERING; FLOWCHARTING; MATERIALS; MUSCLE; SCAFFOLDS (BIOLOGY); SODIUM DODECYL SULFATE; STEM CELLS; SULFUR COMPOUNDS;

ARTERIAL GRAFTS; EXTRACELLULAR MATRICES; HAIR FOLLICLES; MESENCHYMAL STEM CELL; PHYSIOLOGICAL FUNCTIONS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR SMOOTH MUSCLES; VESSEL SCAFFOLD;

BLOOD VESSELS;

DODECYL SULFATE SODIUM; ENDOGLIN; HERMES ANTIGEN; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TRYPSIN; COLLAGEN; GLYCOSAMINOGLYCAN;

ADIPOCYTE; ARTERY GRAFT; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL ISOLATION; EXTRACELLULAR MATRIX; HAIR FOLLICLE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; OSTEOBLAST; UMBILICAL ARTERY; VASCULAR SMOOTH MUSCLE; BLOOD VESSEL PROSTHESIS; CELL CULTURE; CYTOLOGY; ENDOTHELIUM CELL; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; TISSUE SCAFFOLD;

BLOOD VESSEL PROSTHESIS; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN; ENDOTHELIAL CELLS; GLYCOSAMINOGLYCANS; HAIR FOLLICLE; HUMANS; MESENCHYMAL STROMAL CELLS; MYOCYTES, SMOOTH MUSCLE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; UMBILICAL ARTERIES;

EID: 84919882456     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-014-1061-1     Document Type: Article

References (46)

1. Allaire, E., P. Bruneval, C. Mandet, J. P. Becquemin, and J. B. Michel. The immunogenicity of the extracellular matrix in arterial xenografts. Surgery 122:73–81, 1997.
2. Amiel, G. E., M. Komura, O. Shapira, J. J. Yoo, S. Yazdani, J. Berry, S. Kaushal, J. Bischoff, A. Atala, and S. Soker. Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Eng. 12:2355–2365, 2006.
3. Baim, D. S. Percutaneous treatment of saphenous vein graft disease: the ongoing challenge. J. Am. Coll. Cardiol. 42:1370–1372, 2003.
4. Birchall, M., and G. Hamilton. Tissue-engineered vascular replacements for children. Lancet 380:197–198, 2012.
5. Bitter, T., and H. M. Muir. A modified uronic acid carbazole reaction. Anal. Biochem. 4:330–334, 1962.
6. Cervera, R. P., and M. Stojkovic. Commentary: somatic cell nuclear transfer-progress and promise. Stem Cells 26:494–495, 2008.
7. Chou, M. T., S. N. Chang, C. Ke, H. I. Chang, M. L. Sung, H. C. Kuo, and C. N. Chen. The proliferation and differentiation of placental-derived multipotent cells into smooth muscle cells on fibrillar collagen. Biomaterials 31:4367–4375, 2010.
8. Dahl, S. L., J. Koh, V. Prabhakar, and L. E. Niklason. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant. 12:659–666, 2003.
9. Daniel, J., K. Abe, and P. S. McFetridge. Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications. ASAIO J. 51:252–261, 2005.
10. Dardik, H. The second decade of experience with the umbilical vein graft for lower-limb revascularization. Cardiovasc. Surg. 3:265–269, 1995.
11. Dardik, H., N. Miller, A. Dardik, I. Ibrahim, B. Sussman, S. M. Berry, F. Wolodiger, M. Kahn, and I. Dardik. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. J. Vasc. Surg. 7:336–346, 1988.
12. Dardik, H., K. Wengerter, F. Qin, A. Pangilinan, F. Silvestri, F. Wolodiger, M. Kahn, B. Sussman, and I. M. Ibrahim. Comparative decades of experience with glutaraldehydetanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases. J. Vasc. Surg. 35:64–71, 2002.
13. de Valence, S., J. C. Tille, J. P. Giliberto, W. Mrowczynski, R. Gurny, B. H. Walpoth, and M. Möller. Advantages of bilayered vascular grafts for surgical applicability and tissue regeneration. Acta biomater. 8:3914–3920, 2012.
14. Eagle, K. A., R. A. Guyton, R. Davidoff, F. H. Edwards, G. A. Ewy, T. J. Gardner, J. C. Hart, H. C. Herrmann, L. D. Hillis, A. M. Hutter, Jr., B. W. Lytle, R. A. Marlow, W. C. Nugent, and T. A. Orszulak. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110:e340–e437, 2004.
15. Elkins, R. C., M. M. Lane, S. B. Capps, C. McCue, and P. E. Dawson. Humoral immune response to allograft valve tissue pretreated with an antigen reduction process. Semin. Thorac. Cardiovasc. Surg. 13:82–86, 2001.
16. Gui, L., A. Muto, S. A. Chan, C. K. Breuer, and L. E. Niklason. Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng. Part A. 15:2665–2676, 2009.
17. Hochedlinger, K., and R. Jaenisch. Nuclear reprogramming and pluripotency. Nature 441:1061–1067, 2006.
18. Hoogduijn, M. J., E. Gorjup, and P. G. Genever. Comparative characterization of hair follicle dermal stem cells and bone marrow mesenchymal stem cells. Stem Cells Dev. 15:49–60, 2006.
19. Hoopes, C. W., and J. F. Platt. Molecular strategies for clinical xenotransplantation in cardiothoracic surgery. Semin. Thorac. Cardiovasc. Surg. 8:156–174, 1996.
20. Jahoda, C. A., J. Whitehouse, A. J. Reynolds, and N. Hole. Hair follicle dermal cells differentiate into adipogenic and osteogenic lineages. Exp. Dermatol. 12:849–859, 2003.
21. Krawiec, J. T., and D. A. Vorp. Adult stem cell-based tissue engineered blood vessels: a review. Biomaterials 33:3388–3400, 2012.
22. Krenning, G., J. R. Moonen, M. J. van Luyn, and M. C. Harmsen. Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to-mesenchymal transdifferentiation (EnMT) on collagen matrices. Biomaterials 29:3703–3711, 2008.
23. Lako, M., L. Armstrong, P. M. Cairns, S. Harris, N. Hole, and C. A. Jahoda. Hair follicle dermal cells repopulate the mouse haematopoietic system. J. Cell Sci. 115:3967–3974, 2002.
24. Liu, J. Y., H. F. Peng, and S. T. Andreadis. Contractile smooth muscle cells derived from hair-follicle stem cells. Cardiovasc. Res. 79:24–33, 2008.
25. Liu, J. Y., H. F. Peng, S. Gopinath, J. Tian, and S. T. Andreadis. Derivation of functional smooth muscle cells from multipotent human hair follicle mesenchymal stem cells. Tissue Eng. Part A. 16:2553–2564, 2010.
26. Liu, X., L. Song, J. Liu, S. Wang, X. Tan, X. Bai, T. Bai, Y. Wang, M. Li, Y. Song, and Y. Li. miR-18b inhibits TGF-β1-induced differentiation of hair follicle stem cells into smooth muscle cells by targeting SMAD2. Biochem. Biophys. Res. Commun. 438:551–556, 2013.
27. Liu, J. Y., D. D. Swartz, H. F. Peng, S. F. Gugino, J. A. Russell, and S. T. Andreadis. Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc. Res. 75:618–628, 2007.
28. Meyer, S. R., J. Nagendran, L. S. Desai, G. R. Rayat, T. A. Churchill, C. C. Anderson, R. V. Rajotte, J. R. Lakey, and D. B. Ross. Decellularization reduces the immune response to aortic valve allografts in the rat. J. Thorac. Cardiovasc. Surg. 130:469–476, 2005.
29. Peng, H. F., J. Y. Liu, S. T. Andreadis, and D. D. Swartz. Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineering mechanically robust and vasoreactive vascular media. Tissue Eng. Part A. 17:981–990, 2011.
30. Rashid, S. T., B. Fuller, G. Hamilton, and A. M. Seifalian. Tissue engineering of a hybrid bypass graft for coronary and lower limb bypass surgery. FASEB J. 22:2084–2089, 2008.
31. Rieder, E., A. Nigisch, B. Dekan, M. T. Kasimir, F. Mühlbacher, E. Wolner, P. Simon, and G. Weigel. Granulocyte-based immune response against decellularized or glutaraldehyde cross-linked vascular tissue. Biomaterials 27:5634–5642, 2006.
32. Robotin-Johnson, M. C., P. E. Swanson, D. C. Johnson, R. B. Schuessler, and J. L. Cox. An experimental model of small intestinal submucosa as a growing vascular graft. J. Thorac. Cardiovasc. Surg. 116:805–811, 1998.
33. Rodolfa, K. T., and K. Eggan. A transcriptional logic for nuclear reprogramming. Cell 126:652–655, 2006.
34. Sandusky, G. E., G. C. Lantz, and S. F. Badylak. Healing comparison of small intestine submucosa and ePTFE grafts in the canine carotid artery. J. Surg. Res. 58:415–420, 1995.
35. Schaner, P. J., N. D. Martin, T. N. Tulenko, I. M. Shapiro, N. A. Tarola, R. F. Leichter, R. A. Carabasi, and P. J. Dimuzio. Decellularized vein as a potential scaffold for vascular tissue engineering. J. Vasc. Surg. 40:146–153, 2004.
36. Shinoka, T., D. Shum-Tim, P. X. Ma, R. E. Tanel, N. Isogai, R. Langer, J. P. Vacanti, and J. E. Mayer, Jr. Creation of viable pulmonary artery autografts through tissue engineering. J. Thorac. Cardiovasc. Surg. 115:536–545, 1998.
37. Torikai, K., H. Ichikawa, K. Hirakawa, G. Matsumiya, T. Kuratani, S. Iwai, A. Saito, N. Kawaguchi, N. Matsuura, and Y. Sawa. A self-renewing, tissue-engineered vascular graft for arterial reconstruction. J. Thorac. Cardiovasc. Surg. 136:37–45, 2008.
38. Tschoeke, B., T. C. Flanagan, A. Cornelissen, S. Koch, A. Roehl, M. Sriharwoko, J. S. Sachweh, T. Gries, T. Schmitz-Rode, and S. Jockenhoevel. Development of a composite degradable/nondegradable tissue-engineered vascular graft. Artif. Organs 32:800–809, 2008.
39. Tu, J. V., C. L. Pashos, C. D. Naylor, E. Chen, S. L. Normand, J. P. Newhouse, and B. J. McNeil. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N. Engl. J. Med. 336:1500–1505, 1997.
40. Wang, K., Y. Guan, Y. Liu, M. Zhu, T. Li, D. An, L. Ou, Y. Che, G. Zhang, J. Zhang, X. L. Zheng, and D. Kong. Fibrin glue with autogenic bone marrow mesenchymal stem cells for urethral injury repair in rabbit model. Tissue Eng. Part A. 18:23–24, 2012.
41. Wang, Y., J. Liu, X. Tan, G. Li, Y. Gao, X. Liu, L. Zhang, and Y. Li. Induced pluripotent stem cells from human hair follicle mesenchymal stem cells. Stem Cell Rev. 9:451–460, 2012.
42. Weinberg, C. B., and E. Bell. A blood vessel model constructed from collagen and cultured vascular cells. Science 231:397–400, 1986.
43. Wells, W., M. Malas, C. J. Baker, S. M. Quardt, and M. L. Barr. Depopulated vena caval homograft: a new venous conduit. J. Thorac. Cardiovasc. Surg. 126:498–503, 2003.
44. Woessner, Jr., J. F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 93:440–447, 1961.
45. Yu, H., D. Fang, S. M. Kumar, L. Li, T. K. Nguyen, G. Acs, M. Herlyn, and X. Xu. Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am. J. Pathol. 168:1879–1888, 2006.
46. Zhang, X., Y. Wang, Y. Gao, X. Liu, T. Bai, M. Li, L. Li, G. Chi, H. Xu, F. Liu, J. Y. Liu, and Y. Li. Maintenance of high proliferation and multipotent potential of human hair follicle -derived mesenchymal stem cells by growth factors. Int. J. Mol. Med. 31:913–921, 2013.